SCDOT Momentum 2050 Plan
COLUMBIA, S.C. (WSPA) – The General Assembly tasked the South Carolina Department of Transportation with making their Momentum 2050 Plan. The plan outlines goals and future improvements the South Carolina Department of Transportation wants to make.
'Yeah, it is a good way off 2050. But if we don't start funding and preparing and permitting now, we're never going to get there, ' said Senator Larry Grooms, Chairman of the Senate Transportation Committee (R – Berkely).
The South Carolina Department of Transportation said the state has changed drastically since the last plan was made. Secretary at SCDOT, Justin Powell said after the Covid-19 pandemic, there have been 360,000 new residents who have come to the Palmetto State.
They are expecting a million more new residents within the next 20 years.
'The questions are not about the pothole anymore. It's the 'I can't get across town like I used to,' it's those questions,' Powell said.
Grooms said they are committed to working with SCDOT on funding.
'We underfunded our roads for about 25 years. So, for 25 years in a row, our roads got worse, and now that we're getting too good, getting our handle, getting a handle on that, now we need to understand we have to do more to be able to expand the network,' said Grooms.
'Our roads have to be safe, and any unsafe bridges have to be repaired,' Grooms added. 'Now, we know others are aging out, so coming up with a schedule of which bridges get replaced and that's essential in having the revenue to do it.'
Another key issue addressed was railroad repairs and crossings.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
8 minutes ago
- CBS News
RFK Jr. taps allies and COVID vaccine critics among picks for CDC advisory panel. Here's who's on the list.
Health and Human Services Robert F. Kennedy Jr. announced Wednesday he's naming eight new advisers to serve on the Centers for Disease Control and Prevention's vaccine recommendations committee, after firing the committee's entire previous roster of 17 advisers. "All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense. They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations," Kennedy said Wednesday in a post on X. Kennedy's picks circumvented the usual CDC process for selecting members of the Advisory Committee on Immunization Practices. In previous administrations, career agency officials — not political leaders — vetted potential experts before forwarding them to the department for the secretary's approval. The panel's influential recommendations are closely watched because they are directly tied to federal policies, like which vaccines insurers are required to cover. The picks announced by Kennedy include some close allies of the secretary and his inner circle. One of them, Dr. Robert Malone, worked on early research related to mRNA vaccine technology but was accused during the COVID-19 pandemic of spreading misinformation about the mRNA vaccines. He was with Kennedy and President Trump at the Trump election night celebration in Florida. "On the basis of data from all over the world, approximately three years ago it was my impression that the risk/benefit ratio of these products did not merit continued use in any cohort," Malone posted last month on his Substack about the mRNA COVID vaccines. Like Kennedy, Malone has questioned the benefits of measles vaccines during the recent record outbreak in Texas, which killed two children, and he has promoted unproven treatments for the virus. Another member picked by Kennedy is Dr. Martin Kulldorff, an epidemiologist who co-authored the pandemic-era Great Barrington Declaration criticizing COVID-19 restrictions, along with now-NIH Director Dr. Jay Bhattacharya. Bhattacharya has described Kulldorff as a close friend. Kulldorff previously worked with the CDC's outside vaccine advisers, before authoring an opinion piece in 2021 criticizing the agency's decision to pause use of Johnson & Johnson's COVID-19 vaccine over safety concerns. He claimed he was fired from working with the committee over the opinion piece. Kulldorff later claimed he was fired from Harvard University for criticizing COVID-19 vaccine requirements. Dr. Cody Meissner, a pediatrics professor who previously served as a member of the Food and Drug Administration's own vaccines panel — the Vaccines and Related Biological Products Advisory Committee – was also named to the committee. Meissner opposed COVID-19 vaccine requirements for children. He also co-authored an opinion piece with now-FDA Commissioner Dr. Marty Makary speaking out against masking of children during the pandemic. Another former member of the FDA vaccines panel who was picked by Kennedy is Vicky Pebsworth, a regional director of the National Association of Catholic Nurses. Pebsworth spoke at a 2020 meeting of the FDA vaccines committee, where she identified herself as the research director for the National Vaccine Information Center and "mother of a child injured by his 15-month well-baby shots in 1998." She said the center's position was that any "coercion and sanctions to persuade adults to take an experimental vaccine, or give it to their children, is unethical and unlawful." Kennedy also praised another pick, MIT professor Retsef Levi, saying: "Dr. Levi has collaborated with public health agencies to evaluate vaccine safety, including co-authoring studies on mRNA COVID-19 vaccines and their association with cardiovascular risks." Levi previously called for more detailed data from the COVID-19 vaccine trials, suggesting that changes to how Pfizer's shot was produced may have caused side effects. But Levi faced criticism for a paper co-authored with Florida Surgeon General Dr. Joseph Ladapo, which was cited in the state's move to recommend that young men not get mRNA COVID-19 vaccines. Experts condemned the paper for misleading methods that could inflate the risk. The views on vaccines of several of Kennedy's other picks are less clear. Kennedy said Dr. Michael A. Ross "contributed to national strategies for cancer prevention and early detection, including those involving HPV immunization," working with the CDC's breast and cervical cancer committee. Ross is described by Kennedy as an obstetrics and gynecology professor at George Washington University and Virginia Commonwealth University, though his name does not appear on directories for either university. Spokespeople for the two institutions did not immediately respond to a request for comment. Dr. James Pagano, described by Kennedy as a "strong advocate for evidence-based medicine," appears to have published little about vaccines or medicine. Records from the Medical Board of California list Pagano as being retired. Another Kennedy pick, Dr. Joseph Hibbeln, retired from the National Institutes of Health in 2020. His research portfolio previously covered nutritional intake of fatty acids like omega-3. Kennedy described him as bringing "expertise in immune-related outcomes, psychiatric conditions, and evidence-based public health strategies."
CNN
44 minutes ago
- CNN
Kennedy names new members of CDC vaccine advisory panel days after removing previous advisers
Vaccines Federal agencies Respiratory virusesFacebookTweetLink Follow Just two days after retiring the entirety of the US Centers for Disease Control and Prevention's vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government's Covid-19 response to that committee. He announced eight new members of the CDC's Advisory Committee on Immunization Practices, or ACIP, on Wednesday. Kennedy had said Monday that the previous 17-member panel that makes recommendations on who should get vaccines and when was rife with conflicts of interest and that he would appoint new 'highly credentialed' experts in time for the panel's June 25 meeting, at which the members are expected to discuss guidance for Covid-19 and HPV shots, among others. In a statement Wednesday, Kennedy said the reassembled panel will demand 'definitive safety and efficacy data before making any new vaccine recommendations, but will also review data for the current vaccine schedule as well.' The eight new ACIP members include Dr. Robert Malone, a biochemist who made early innovations in the field of messenger RNA but in more recent years has been a vocal critic of mRNA technology in Covid-19 vaccines. The CDC recently narrowed its recommendations for mRNA Covid-19 shots, but some advocates in the Make America Healthy Again space have pressed Kennedy to go further and bar the vaccines entirely. Another new member is Dr. Martin Kulldorff, a biostatistician and epidemiologist who co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the US National Institutes of Health. Both Malone's and Kulldorff's names were circulated early in the second Trump administration as potential advisers on ACIP or other panels, according to a person familiar with the process who requested anonymity because they weren't authorized to speak with CNN. Kennedy also chose Dr. James Pagano, an emergency medicine physician he described as a 'strong advocate for evidence-based medicine' who has served on hospital committees and medical executive boards. Dr. Retsef Levi, an MIT professor who has published studies on mRNA vaccines and cardiovascular events, is also joining the panel. Levi is a professor of operations management. Several of the new members have served in federal health agencies previously, including Dr. Joseph Hibbeln, a former acting chief of the NIH's section on nutritional neurosciences. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has previously served on ACIP and on the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Dr. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses, also served on the FDA committee and on a national panel reviewing the 2009 H1N1 swine flu vaccine. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has previously served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. Kennedy also nodded in his statement to Ross' 'continued service on biotech and healthcare boards.' The private equity company Havencrest, in which Ross is an operating partner, describes him on its site as a 'serial CEO' who has served on the boards of several biotechnology companies.
CNN
an hour ago
- CNN
Kennedy names new members of CDC vaccine advisory panel days after removing previous advisers
Just two days after retiring the entirety of the US Centers for Disease Control and Prevention's vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government's Covid-19 response to that committee. He announced eight new members of the CDC's Advisory Committee on Immunization Practices, or ACIP, on Wednesday. Kennedy had said Monday that the previous 17-member panel that makes recommendations on who should get vaccines and when was rife with conflicts of interest and that he would appoint new 'highly credentialed' experts in time for the panel's June 25 meeting, at which the members are expected to discuss guidance for Covid-19 and HPV shots, among others. In a statement Wednesday, Kennedy said the reassembled panel will demand 'definitive safety and efficacy data before making any new vaccine recommendations, but will also review data for the current vaccine schedule as well.' The eight new ACIP members include Dr. Robert Malone, a biochemist who made early innovations in the field of messenger RNA but in more recent years has been a vocal critic of mRNA technology in Covid-19 vaccines. The CDC recently narrowed its recommendations for mRNA Covid-19 shots, but some advocates in the Make America Healthy Again space have pressed Kennedy to go further and bar the vaccines entirely. Another new member is Dr. Martin Kulldorff, a biostatistician and epidemiologist who co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the US National Institutes of Health. Both Malone's and Kulldorff's names were circulated early in the second Trump administration as potential advisers on ACIP or other panels, according to a person familiar with the process who requested anonymity because they weren't authorized to speak with CNN. Kennedy also chose Dr. James Pagano, an emergency medicine physician he described as a 'strong advocate for evidence-based medicine' who has served on hospital committees and medical executive boards. Dr. Retsef Levi, an MIT professor who has published studies on mRNA vaccines and cardiovascular events, is also joining the panel. Levi is a professor of operations management. Several of the new members have served in federal health agencies previously, including Dr. Joseph Hibbeln, a former acting chief of the NIH's section on nutritional neurosciences. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has previously served on ACIP and on the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Dr. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses, also served on the FDA committee and on a national panel reviewing the 2009 H1N1 swine flu vaccine. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has previously served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. Kennedy also nodded in his statement to Ross' 'continued service on biotech and healthcare boards.' The private equity company Havencrest, in which Ross is an operating partner, describes him on its site as a 'serial CEO' who has served on the boards of several biotechnology companies.
